3 Results for "

lipidated

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "lipidated" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-111550
CAS No.: 342795-08-8
Purity:  99.85%
Target:  

Ras MDM-2/p53

Research Areas:  

Cancer

Bragsin2 is a potent, selective and noncompetitive nucleotide exchange factor BRAG2 inhibitor, with an IC50 of 3 μM. Bragsin2 binds at the interface between the PH domain of BRAG2 and the lipid bilayer, leads BRAG2 unable to activate lipidated Arf GTPase. Bragsin2 affects breast cancer stem cells .
loading...
    loading...
Cat. No.: HY-123058
CAS No.: 1383716-46-8
Purity:  99.19%
Target:  

PI3K Autophagy

Research Areas:  

Cancer

Vps34-IN-4 is an orally active and selective VPS34 inhibitor with an IC50 of 15 nM against human VPS34. Vps34-IN-4 binds to the ATP-binding pocket of VPS34. Vps34-IN-4 inhibits autophagy (autophagy) by blocking the degradation of autophagic substrates and increasing both lipidated and non-lipidated forms of LC3. Vps34-IN-4 induces time-dependent LC3-II accumulation in tumor tissues of tumor-bearing mice. Vps34-IN-4 can be used for research on cancers such as colon cancer .
loading...
    loading...
Cat. No.: HY-111550R
CAS No.: 342795-08-8
Research Areas:  

Cancer

Bragsin2 (Standard) is the analytical standard of Bragsin2 (HY-111550). This product is intended for research and analytical applications. Bragsin2 is a potent, selective and noncompetitive nucleotide exchange factor BRAG2 inhibitor, with an IC50 of 3 μM. Bragsin2 binds at the interface between the PH domain of BRAG2 and the lipid bilayer, leads BRAG2 unable to activate lipidated Arf GTPase. Bragsin2 affects breast cancer stem cells .
loading...
    loading...